日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer

抑制ATR-Chk1信号通路作为提高尿路上皮膀胱癌对顺铂化疗敏感性的治疗策略

Li, Ching-Chia; Yang, Juan-Cheng; Lu, Mei-Chin; Lee, Chia-Lin; Peng, Chieh-Yu; Hsu, Wei-Yu; Dai, Yun-Hao; Chang, Fang-Rong; Zhang, Da-Yong; Wu, Wen-Jeng; Wu, Yang-Chang

Novel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo

新型口服组蛋白去乙酰化酶抑制剂MPT0E028在体外和体内均显示出对人B细胞淋巴瘤的强效生长抑制活性。

Huang, Han-Li; Peng, Chieh-Yu; Lai, Mei-Jung; Chen, Chun-Han; Lee, Hsueh-Yun; Wang, Jing-Chi; Liou, Jing-Ping; Pan, Shiow-Lin; Teng, Che-Ming

CHM-1, a new vascular targeting agent, induces apoptosis of human umbilical vein endothelial cells via p53-mediated death receptor 5 up-regulation.

CHM-1 是一种新型血管靶向剂,它通过 p53 介导的死亡受体 5 上调诱导人脐静脉内皮细胞凋亡

Tsai An-Chi, Pan Shiow-Lin, Sun Hui-Lung, Wang Chih-Ya, Peng Chieh-Yu, Wang Shih-Wei, Chang Ya-Ling, Kuo Sheng-Chu, Lee Kuo-Hsiung, Teng Che-Ming

Antitumor agents. 256. Conjugation of paclitaxel with other antitumor agents: evaluation of novel conjugates as cytotoxic agents

抗肿瘤药物。256. 紫杉醇与其他抗肿瘤药物的偶联:新型偶联物作为细胞毒性药物的评价

Nakagawa-Goto, Kyoko; Nakamura, Seikou; Bastow, Kenneth F; Nyarko, Alexander; Peng, Chieh-Yu; Lee, Fang-Yu; Lee, Fang-Chen; Lee, Kuo-Hsiung